Analyst Price Target is $6.75
▲ +173.28% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for 22nd Century Group in the last 3 months. The average price target is $6.75, with a high forecast of $8.50 and a low forecast of $5.00. The average price target represents a 173.28% upside from the last price of $2.47.
Current Consensus is
The current consensus among 2 contributing investment analysts is to buy stock in 22nd Century Group.
22nd Century Group, Inc. is a biotechnology company, which develops disruptive plant-based solutions for life science, consumer product, and pharmaceutical markets. It focuses on technologies that alter the level of nicotine in tobacco plants and level of cannabinoids in hemp or cannabis plants through genetic engineering, gene-editing, and modern plant breeding techniques. The company was founded on September 12, 2005 and is headquartered in Buffalo, NY.